HDAC3 and bronchopulmonary dysplasia: Moreover, the expression of miR-17-92 cluster in sh-Hdac3-treated cells was markedly higher than those of sh-NC-treated cells (Fig. 2c), implying that Hdac3 may inhibit the miR-17-92 cluster in BPD.